导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 23.34% | 65/133 |
| 近一周 | -1.77% | 36/152 |
| 近一月 | -4.78% | 52/151 |
| 近一季 | -4.62% | 37/149 |
| 近半年 | 4.47% | 55/142 |
| 近一年 | 25.16% | 53/132 |
| 近两年 | 58.82% | 15/100 |
| 近三年 | 39.45% | 17/72 |
| 成立以来 | 2.03% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
16.14% 90/341 |
2.04% 214/349 |
10.91% 142/355 |
- - |
| 2024 | 27.39% 27/330 |
0.39% 166/280 |
9.13% 30/310 |
20.02% 83/319 |
-3.11% 198/330 |
| 2023 | -12.16% 172/276 |
2.83% 87/205 |
-6.91% 182/230 |
-4.92% 157/262 |
-3.48% 218/276 |
| 2022 | -16.87% 77/202 |
-8.54% 61/153 |
2.18% 60/164 |
-21.02% 125/189 |
12.63% 76/202 |
| 2021 | -21.11% 84/151 |
1.74% 146/312 |
-1.66% 272/328 |
-16.67% 286/358 |
-5.39% 78/151 |
| 2020 | -1.66% 57/104 |
-13.53% 169/280 |
3.07% 260/295 |
-2.35% 223/299 |
13.01% 74/305 |
| 2019 | 11.45% 66/89 |
10.65% 110/258 |
-2.22% 219/268 |
-5.63% 228/253 |
9.16% 85/266 |
| 2018 | -10.12% 50/80 |
- - |
- - |
- - |
-7.78% 91/241 |
| 2017 | 24.09% 17/69 |
- - |
- - |
- - |
- - |
| 2016 | -2.08% 40/59 |
- - |
- - |
- - |
- - |
| 2015 | -19.44% 37/49 |
- - |
- - |
- - |
- - |
| 2014 | 12.28% 20/99 |
- - |
- - |
- - |
- - |
| 2013 | -3.97% 51/70 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 嘉实标普生物科技精选行业ETF(QDII) | 1.2715 | 30.30% |
| 易方达标普生物科技人民币A | 1.7172 | 27.30% |
| 易方达标普生物科技人民币C | 1.6936 | 27.21% |
| 汇添富纳斯达克生物科技ETF(QDII) | 1.4590 | 19.43% |
| 广发生物科技指数美元(QDII)A | 0.2081 | 18.59% |
| 广发生物科技指数人民币(QDII)A | 1.4690 | 17.80% |
| 广发生物科技指数人民币(QDII)C | 1.4450 | 17.77% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现钞 | 1.3424 | 17.75% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币C | 1.3639 | 17.05% |
| 广发全球医疗保健指数人民币(QDII)C | 2.4880 | 10.94% |
| 易方达恒生国企ETF联接现钞A VS. 天弘恒生科技指数(QDII)C(012349) |